"Dear patients, we would like to inform you that due to the restrictions imposed by the resolution of the Cabinet of Ministers №168 dated February 14, 2025, the "TherapyPLUS" program will be forcibly suspended starting from February 25, 2025. If the program is resumed, relevant information will be posted on the program's website," the announcement states.
The representative office of AstraZeneca in Ukraine confirmed that the social program has been halted, reports the publication "Facts".
"Yes, it is true that the program is suspending its operations due to changes in legislation, specifically due to the requirements of the Cabinet of Ministers of Ukraine. Our team is currently working on the possibility of resuming the program, but we do not know how quickly this can be achieved. In the event of the program's resumption, we will notify all patients via SMS," the company representatives told journalists from the publication.
The "Therapy PLUS" program from AstraZeneca included a group of medications used for the treatment of cardiovascular diseases, respiratory system disorders, diabetes, and psychoneurotic disorders, with a fixed discount on the medications.